Ethyl 3-(bromomethyl)-1-benzofuran-2-carboxylate

CAS: 29115-34-2

Ref. 3D-EBA11534

Produktinformation

• Name: Ethyl 3-(bromomethyl)-1-benzofuran-2-carboxylate
• Synonyme: 2-Benzofurancarboxylic Acid, 3-(Bromomethyl)-, Ethyl Ester, 3-Bromomethyl-benzofuran-2-carboxylic acid ethyl ester

Beschreibung

Ethyl 3-(bromomethyl)-1-benzofuran-2-carboxylate (BMC) is a potent anticancer agent that inhibits cancer cell growth by inhibiting the activity of regulatory proteins. BMC selectively interacts with the regulatory domain of these proteins, which causes them to become inactive and inhibits tumor growth. BMC also induces necroptosis, which is an alternative form of programmed cell death that can be induced by multiple stimuli. This process results in the release of proinflammatory cytokines such as IL-1β and IL-18, which may contribute to its anti-cancer effects. BMC has been shown to inhibit murine lung tumor growth in vivo and inhibit tumor growth in vitro.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 283.12 g/mol
• Formel: C₁₂H₁₁BrO₃
• Reinheit: Min. 95%